PP
CELG

Palladium Partners’s Celgene Corp CELG Stock Holding History

Palladium Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,544
Closed -$225K – 265
2017
Q3 		$225K Buy
+1,544
New +$210K 0.02% 247
2014
Q2 		– Sell
-600
Closed -$42K – 537
2014
Q1 		$42K Buy
+600
New +$47.5K ﹤0.01% 359
2013
Q4 		– Sell
-600
Closed -$46K – 559
2013
Q3 		$46K Hold
600
– – ﹤0.01% 352
2013
Q2 		$35K Buy
+600
New +$36.1K ﹤0.01% 374

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Palladium Partners's CELG Position: Q4 2017 in Review

Palladium Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,544 shares — an estimated $225K sold.

Palladium Partners first reported a position in CELG in Q2 2013 and held it in 4 quarters. The position peaked at $225K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Palladium Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Palladium Partners sold 1,544 Celgene Corp shares in Q4 2017, an estimated $225K.
  • Palladium Partners first reported a position in Celgene Corp in Q2 2013 and held it in 4 quarters.
  • Palladium Partners's Celgene Corp position peaked at $225K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Palladium Partners's 13F filing for Q4 2017, filed 5 Feb 2018.